Carlo Milandri
- Oncology top 5%
- Pancreatic and Hepatic Oncology Research 13
- Cancer Treatment and Pharmacology 13
- Colorectal Cancer Treatments and Studies 12
- HER2/EGFR in Cancer Research 6
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 8
- Breast Cancer Treatment Studies 8
-
- Gastric Cancer Management and Outcomes 6
-
- Neuroendocrine Tumor Research Advances 5
- Co-authors
- Giovanni Luca FrassinetiWainer ZoliPaolo PassoniMichele ReniValerio Di CarloStefano CordioDino AmadoriAlessandro Passardi
- Journals
- Journal of Clinical Oncology (6 papers)SHILAP Revista de lepidopterología (1 paper)The Lancet Oncology (1 paper)
- Partner nations
- ItalyGermanyUnited States
In The Last Decade
Carlo Milandri
48 papers receiving 909 citations
Peers
Comparison fields: 5 of 79
- Oncology 677
- Cancer Research 273
- Pulmonary and Respiratory Medicine 261
- Epidemiology 211
- Biotechnology 44
Countries citing papers authored by Carlo Milandri
This map shows the geographic impact of Carlo Milandri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlo Milandri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlo Milandri more than expected).
Fields of papers citing papers by Carlo Milandri
This network shows the impact of papers produced by Carlo Milandri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlo Milandri. The network helps show where Carlo Milandri may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Carlo Milandri, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 10 | |
| 2 | 2021 | 8 | |
| 3 | 2019 | 37 | |
| 4 | GEMOX plus tomotherapy for unresectable locally advanced pancreatic cancer. | 2011 | 7 |
| 5 | 2011 | 14 | |
| 6 | 2011 | 20 | |
| 7 | 2010 | 9 | |
| 8 | 2010 | 15 | |
| 9 | 2008 | 4 | |
| 10 | 2007 | 7 | |
| 11 | 2006 | 11 | |
| 12 | 2006 | 62 | |
| 13 | 2003 | 10 | |
| 14 | 1998 | 10 | |
| 15 | 1998 | 11 | |
| 16 | 1997 | 73 | |
| 17 | A phase I/II study of sequential doxorubicin and paclitaxel in the treatment of advanced breast cancer. | 1996 | 35 |
| 18 | 1996 | 2 | |
| 19 | 1995 | 27 | |
| 20 | 1994 | 5 |
About Carlo Milandri
Carlo Milandri is a scholar working on Oncology, Cancer Research and Gastroenterology, having authored 53 papers that have together received 936 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (13 papers), Cancer Treatment and Pharmacology (13 papers), Colorectal Cancer Treatments and Studies (12 papers), Cancer Genomics and Diagnostics (8 papers), Breast Cancer Treatment Studies (8 papers), HER2/EGFR in Cancer Research (6 papers), Gastric Cancer Management and Outcomes (6 papers) and Neuroendocrine Tumor Research Advances (5 papers). The work is most often cited by research in Oncology (677 citations), Cancer Research (273 citations) and Pulmonary and Respiratory Medicine (261 citations). Carlo Milandri has collaborated with scholars based in Italy, Germany and United States. Frequent co-authors include Giovanni Luca Frassineti, Wainer Zoli, Paolo Passoni, Michele Reni, Valerio Di Carlo, Stefano Cordio, Dino Amadori, Alessandro Passardi, Gianpaolo Balzano and E. Bonetto. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.